Mark Nellist

Mark Nellist is a Researcher in the Department of Clinical Genetics at Erasmus MC, where he focuses on the molecular genetics of Tuberous Sclerosis Complex (TSC) and related neurogenetic disorders. His work integrates genomic sequencing, functional assays, and RNA splicing analysis to improve diagnostic accuracy and variant classification.

His research interests center on clinical and molecular genetics, particularly in understanding the pathogenicity of variants in TSC1 and TSC2 genes, mechanisms of incomplete penetrance, and functional impacts of mutations in TSC and related syndromes such as Neurofibromatosis Type 1 and Legius Syndrome. His work contributes significantly to precision diagnostics and genetic counseling.

The recent publications show a strong trend in functional genomics and molecular diagnostics, with a focus on improving classification of genetic variants through integrated assays. His studies often involve international collaborations and utilize cutting-edge genomic and molecular techniques to resolve diagnostically challenging cases.

Mark Nellist has not been publicly associated with any scientific awards in the provided text.

There is no information available regarding student advising, research grants, or leadership of labs or research teams in the current data.